上市

Search documents
皓元医药: 上海皓元医药股份有限公司关于发行股份及支付现金购买资产并募集配套资金暨关联交易之部分限售股上市流通公告
Zheng Quan Zhi Xing· 2025-07-08 09:13
关联交易之部分限售股上市流通公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示: ? 本次股票上市类型为向特定对象发行股份;股票认购方式为网下,上市股 数为4,493,210股。 本次股票上市流通总数为4,493,210股。 证券代码:688131 证券简称:皓元医药 公告编号:2025-088 转债代码:118051 转债简称:皓元转债 上海皓元医药股份有限公司 关于发行股份及支付现金购买资产并募集配套资金暨 ? 本次股票上市流通日期为2025 年 7 月 16 日。 一、本次上市流通的限售股类型 根据中国证券监督管理委员会(以下简称"中国证监会")于 2022 年 11 月 25 日出具的《关于同意上海皓元医药股份有限公司向 WANG YUAN(王元)等发行 股份购买资产并募集配套资金注册的批复》 (证监许可20223042 号),同意公司向 特定对象 WANG YUAN(王元)、上海源盟企业管理咨询合伙企业(有限合伙) (以 下简称"上海源盟")、宁波九胜创新医药科技有限公司、上海源黎企业管理合伙 企 ...
瑞达期货股指期货全景日报-20250708
Rui Da Qi Huo· 2025-07-08 08:53
| 项目类别 | 数据指标 | 最新 | 环比 数据指标 | 最新 | 环比 | | --- | --- | --- | --- | --- | --- | | | IF主力合约(2509) | 3958.6 | +39.2↑ IF次主力合约(2507) | 3982.4 | +36.0↑ | | | IH主力合约(2509) | 2727.8 | +18.8↑ IH次主力合约(2507) | 2733.0 | +18.2↑ | | | IC主力合约(2509) | 5858.0 | +106.6↑ IC次主力合约(2507) | 5958.0 | +95.2↑ | | | IM主力合约(2509) | 6235.8 | +123.0↑ IM次主力合约(2507) | 6379.8 | +110.6↑ | | | IF-IH当月合约价差 | 1249.4 | +18.0↑ IC-IF当月合约价差 | 1975.6 | +61.4↑ | | 期货盘面 | IM-IC当月合约价差 | 421.8 | +13.8↑ IC-IH当月合约价差 | 3225.0 | +79.4↑ | | | IM-IF当月合约价差 | ...
仟源医药:子公司获依巴斯汀化学原料药上市批准
news flash· 2025-07-08 08:49
仟源医药(300254)公告,子公司江苏嘉逸医药有限公司收到国家药品监督管理局签发的依巴斯汀《化 学原料药上市申请批准通知书》。依巴斯汀适用于伴有或不伴有过敏性结膜炎的过敏性鼻炎及慢性特发 性荨麻疹的对症治疗。依巴斯汀原研为INDUSTRIAS FARMACEUTICAS ALMIRALL,S.A.,子公司杭 州仟源保灵药业有限公司的依巴斯汀片已通过一致性评价,该品种已进入国家医保目录乙类。依巴斯汀 原料药获批上市后,将进一步降低制剂产品的生产成本,增强产品的市场竞争力。 ...
A股上市公司理财图鉴:券商产品逆势增长,收益凭证成新宠
Sou Hu Cai Jing· 2025-07-08 08:38
将闲置资金用于理财,已成为A股上市公司提升资金效率的重要手段。Wind数据显示,2025年上半年(按认购日期 计),653家A股上市公司合计斥资4113.35亿元购买理财产品,尽管总规模较去年同期有所收缩,但券商理财产品的认 购比例却从5.62%逆势攀升至7.6%,认购金额突破312.71亿元,成为市场关注的焦点。 理财市场整体缩量,券商产品逆势突围 从产品结构看,上市公司理财偏好呈现分化。上半年,结构性存款以2374.26亿元规模居首,银行理财产品、存款产 品、逆回购产品分别以478.45亿元、311.3亿元、245.78亿元紧随其后。相比之下,信托、通知存款等传统品类认购规模 不足150亿元,显示市场风险偏好趋于谨慎。 深圳市前海排排网基金销售有限责任公司研究部副总监刘有华分析指出:"理财产品整体收益率下滑及净值波动加剧, 是上市公司配置意愿减弱的主要原因。"在此背景下,券商理财产品凭借差异化优势实现突围,159家上市公司合计认购 312.71亿元,其中65家认购金额超1亿元,江苏国泰、瑞泰新材等企业更以数十亿元规模领跑。 收益凭证受青睐,灵活性与安全性兼具 券商理财产品中,收益凭证以绝对优势成为"宠儿" ...
百惠金控:香港IPO市场重回“世一” 超210家企业蓄势待发
Cai Fu Zai Xian· 2025-07-08 07:48
Group 1 - The Hong Kong IPO market showed strong performance in the first half of 2025, with total fundraising reaching HKD 107.1 billion, a sevenfold increase compared to the same period last year, reclaiming the title of "world's first" in IPO fundraising [1][2] - The number of new listings on the main board increased significantly, with 42 new IPOs, representing a 47% year-on-year growth [1][2] - The main board's new listings were primarily concentrated in the retail, consumer goods, and services sector (34%), followed by industrial and materials, and medical and pharmaceutical sectors (each accounting for 23%) [1][2] Group 2 - The strong market performance is attributed to a surge in large IPOs and the continued popularity of the "A+H" listing model, which accounted for over 70% of the total fundraising in Hong Kong [3] - Leading domestic companies utilizing the "A+H" model are expanding their financing channels and accelerating their global presence, contributing to a positive market cycle [3] - The market is expected to maintain a favorable atmosphere, with over 200 companies currently waiting to go public, particularly in technology innovation, medical and pharmaceutical, and industrial sectors [3]
【IPO前哨】三家连锁餐企上市飘红,老乡鸡赴港胜算如何?
Sou Hu Cai Jing· 2025-07-08 07:31
Group 1 - Three chain restaurants have gone public in Hong Kong in 2023, with notable stock performance: Dashi Holdings (01405.HK) up 116.74%, Xiaocaiyuan (00999.HK) up 25.65%, and Green Tea Group (06831.HK) up 31.57% since their IPOs [2][3] - Dashi Holdings, the operator of Domino's Pizza in Greater China, has seen its stock price rise from an IPO price of 46.00 HKD to 99.70 HKD [2][3] - Xiaocaiyuan and Green Tea Group also reported positive stock performance since their IPOs, with current prices of 10.68 HKD and 9.46 HKD respectively [2][3] Group 2 - Laoxiangji, a chain restaurant based in Anhui, has submitted an application for an IPO in Hong Kong, aiming to replicate the success of other listed chain restaurants [2][3] - Established in 2003, Laoxiangji has expanded its network to 1,564 stores across 58 cities by April 2025, with a focus on a "direct + franchise" expansion model [4][5] - The number of franchise stores has outpaced self-operated stores, with a significant increase in franchise locations from 118 to 653 between the end of 2022 and April 2025 [5] Group 3 - Laoxiangji's supply chain is a key advantage, having established an integrated supply chain covering breeding, procurement, processing, storage, and logistics [7] - In 2024, Laoxiangji reported total revenue of 6.288 billion RMB and an adjusted net profit of 439 million RMB, resulting in a net profit margin of 6.99% [7][8] - Compared to other newly listed chain restaurants, Laoxiangji's same-store sales growth rate of 2.6% is slightly higher than Dashi Holdings' 2.5%, while Green Tea and Xiaocaiyuan reported negative growth [7][8] Group 4 - Laoxiangji faces challenges, including intense competition from food delivery platforms affecting both delivery and dine-in services [9] - The company has a high dependency on the East China market, with 86% of its stores located in this region, particularly in Anhui [9] - Financially, Laoxiangji has a current ratio of 0.74, indicating potential liquidity issues, with cash reserves of approximately 572 million RMB against significant payables [9] Group 5 - The company plans to use the funds raised from the IPO to enhance its supply chain, expand its store network, improve IT capabilities, and strengthen brand marketing [9][10] - However, the recent surge in IPO activities in Hong Kong raises questions about investor interest in Laoxiangji's prospects [10]
7月8日涨停分析
news flash· 2025-07-08 07:18
7月8日涨停分析 今日共67股涨停,连板股总数17只,15股封板未遂,封板率为82%(不含ST股、退市股)。焦点股方面,柳钢股份反包涨停走出6天5板,亚玛顿上演"地天 板"收获5天4板,PCB板块全天领涨,金安国纪4连板,宏和科技6天4板。 | 股票名称 | 板数 | 涨跌幅 | 涨停时间 | 上涨逻辑 | | --- | --- | --- | --- | --- | | 金安国纪 | 4天4板 | 10.02% | 09:37 | 覆铜板+医 | | 002636 | | | | 疗器械 | | 宏和科技 | 6天4板 | 10.02% | 09:50 | 电子级玻 | | 603256 | | | | 年 | | 九鼎新材 | 3天3板 | 10.05% | 13:42 | 电子级玻 | | 002201 | | | | 经 | | 博敏电子 | 6天3板 | 9.98% | 09:30 | PCB+芯片 | | 603936 | | | | | | 平安电工 | 3天2板 | 9.99% | 13:16 | 电子级玻 | | 001359 | | | | 纤布 | | 东材科技 | 3天2板 | 10 ...
星源材质布局“A+H”上市,计划扩大海外网络
Sou Hu Cai Jing· 2025-07-08 05:46
Core Viewpoint - Shenzhen Xingyuan Material Technology Co., Ltd. (Xingyuan Material) has submitted its prospectus for listing on the Hong Kong Stock Exchange, aiming to expand its operations and enhance its market presence in the lithium-ion battery separator manufacturing industry [1][3]. Company Overview - Xingyuan Material was established in September 2003 and was listed on the Shenzhen Stock Exchange's Growth Enterprise Market in December 2016. The company is recognized as a leading manufacturer of lithium-ion battery separators, ranking second globally in shipment volume for the past five years, with a market share increase from 11.0% in 2020 to 14.4% in 2024 [3][4]. - The company has a registered capital of approximately RMB 135 million and is headquartered in Shenzhen, Guangdong Province. Major shareholders include Chen Xiufeng, the National Social Security Fund, and Shenzhen Suyuan Holdings Group [3][4]. Financial Performance - Xingyuan Material's revenue for the years 2022, 2023, 2024, and Q1 2025 was approximately RMB 28.67 billion, RMB 29.82 billion, RMB 35.06 billion, and RMB 8.81 billion, respectively. The gross profit for the same periods was around RMB 12.85 billion, RMB 12.90 billion, RMB 9.84 billion, and RMB 2.08 billion [4][5]. - The net profit figures for the same periods were approximately RMB 7.48 billion, RMB 5.94 billion, RMB 3.71 billion, and RMB 505.11 million, indicating a significant decline in profitability, particularly in 2023 and 2024, with year-on-year decreases of 20.58% and 37.56%, respectively [5][6]. Cost and Margin Analysis - The company's gross margin has been declining, with rates of 44.8% in 2022, 43.3% in 2023, and a sharp drop to 28.1% in 2024. In Q1 2025, the gross margin further decreased to 23.6% [6]. - Increased sales costs have been identified as a primary reason for the "increased revenue but decreased profit" scenario. Additionally, administrative expenses rose from approximately RMB 223 million in 2022 to RMB 331 million in 2023, with a slight decrease to RMB 315 million in 2024 [6]. Future Plans - The funds raised from the Hong Kong listing are intended for expanding overseas networks, including establishing production bases in Malaysia and the United States, and a research and operations center in Singapore. The company also plans to invest in solid-state battery products and new generation lithium-ion battery separators [6][7]. Debt Information - In February 2024, Xingyuan Material secured a loan of EUR 140 million from Luxembourg's招商银行, with a five-year term and an interest rate based on the six-month EURIBOR plus 150 basis points. As of March 31, 2025, the principal of this loan remains unpaid [7].
风口IPO|顺德农商行终止IPO,净利润连续三年下滑不良率四连升
Sou Hu Cai Jing· 2025-07-08 04:43
顺德农商行长达八年的上市征程按下终止键。 7月4日,深交所公告,因广东顺德农村商业银行股份有限公司(下称"顺德农商行")及保荐人撤回IPO申 请,深交所决定终止对其主板上市的审核。 顺德农商行的IPO之路堪称中国银行业上市历程中最漫长的等待之一。早在2017年7月,该行股东大会就审 议通过A股上市议案。两年后的2019年6月,上市申请正式获证监会受理,顺德农商行加入A股排队序列。 图片来源:深交所网站 2024年年报显示,该行净利润31.69亿元,同比下滑8.5%,这已是连续第三年负增长,2025年一季度净利润 进一步大跌39.4%至5亿元。 资产质量持续恶化。截至2024年末,该行不良贷款率升至1.61%,较上年增加0.13个百分点,实现"四连 升"。个人贷款领域风险显露,2024年末,个人不良贷款16.5亿元,同比大增76%,不良率达1.92%。拨备 覆盖率则连续三年下滑至174.78%,逼近监管警戒线。 但这一优势正在被蚕食。2019年至2023年,该行存款市场份额从38.18%降至34.06%,贷款份额从38.07%滑 落至36.24%。面对顺德地区二十余家银行机构的激烈竞争,这家昔日区域霸主正经历" ...
天赐材料拟赴港上市 业绩连降两年2021年定增募16.7亿
Zhong Guo Jing Ji Wang· 2025-07-08 03:24
Core Viewpoint - The company Tianqi Materials plans to issue H-shares and list on the Hong Kong Stock Exchange to enhance its global strategy and competitiveness in the international market [1][2]. Group 1: H-Share Issuance - The company held board and supervisory meetings on July 4, 2025, to approve the proposal for issuing H-shares and listing on the Hong Kong Stock Exchange [1]. - The issuance aims to support the company's global strategy, meet the needs of overseas business development, and improve operational efficiency [1][2]. - The issuance requires approval from the shareholders' meeting and relevant regulatory bodies, including the China Securities Regulatory Commission and the Hong Kong Stock Exchange [2]. Group 2: Financial Performance - In 2024, the company reported a revenue of 12.52 billion yuan, a decrease of 18.74% compared to 2023 [3]. - The net profit attributable to shareholders was 483.93 million yuan, down 74.40% year-on-year [3]. - The net profit after deducting non-recurring gains and losses was 381.60 million yuan, reflecting a decline of 79.08% [3]. - The net cash flow from operating activities was 881.54 million yuan, a decrease of 61.24% compared to the previous year [3]. Group 3: Historical Financial Data - In 2023, the company achieved a revenue of 15.40 billion yuan, down 30.97% from 2022 [4]. - The net profit attributable to shareholders in 2023 was 1.89 billion yuan, a decline of 66.92% year-on-year [4]. - The net profit after deducting non-recurring gains and losses for 2023 was 1.82 billion yuan, down 67.08% compared to 2022 [4]. - The net cash flow from operating activities in 2023 was 2.27 billion yuan, a decrease of 45.38% from 2022 [4].